(Laboratory of Experimental Cancer Research, Department of Radiation Oncology
and Experimental Cancer Research, Ghent University Hospital, Belgium). The human
A3AR construct (
transcript variant 2 of the ADORA3 gene) and human βarr2
construct (
Origene Technologies (Rockville, MD, USA). DOTAP Liposomal Transfection Reagent
was purchased from Sigma Aldrich (Steinheim, Germany), and the anti-dNGFR
antibody was purchased from Chromaprobe (Maryland Heights, MO, USA). Reference
agonists 2-Cl-IB-MECA, IB-MECA, CGS21680 and NECA were purchased from Tocris
Bioscience (Bio-techne, Abingdon, UK). All other chemicals and reagents used
were purchased from the same suppliers as described previously [18 (link)] or synthesized at NIDDK, National Institutes of
Health as reported [19 (link)–33 (link)].